MD3678F1 - Method of diffuse mastopathy treatment - Google Patents

Method of diffuse mastopathy treatment Download PDF

Info

Publication number
MD3678F1
MD3678F1 MDA20070167A MD20070167A MD3678F1 MD 3678 F1 MD3678 F1 MD 3678F1 MD A20070167 A MDA20070167 A MD A20070167A MD 20070167 A MD20070167 A MD 20070167A MD 3678 F1 MD3678 F1 MD 3678F1
Authority
MD
Moldova
Prior art keywords
during
weeks
administered
patient
diet
Prior art date
Application number
MDA20070167A
Other languages
Romanian (ro)
Other versions
MD3678G2 (en
Inventor
Ludmila Etco
Anatol ROTARU
Ala Chiriac
Natalia Zarbailov
Original Assignee
Institutie Medico-Sanitara Publica Institutul De Cercetari Stiintifice In Domeniul Ocrotirii Sanatatii Mamei Si Copilului
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institutie Medico-Sanitara Publica Institutul De Cercetari Stiintifice In Domeniul Ocrotirii Sanatatii Mamei Si Copilului filed Critical Institutie Medico-Sanitara Publica Institutul De Cercetari Stiintifice In Domeniul Ocrotirii Sanatatii Mamei Si Copilului
Priority to MDA20070167A priority Critical patent/MD3678G2/en
Publication of MD3678F1 publication Critical patent/MD3678F1/en
Publication of MD3678G2 publication Critical patent/MD3678G2/en

Links

Landscapes

  • Magnetic Treatment Devices (AREA)

Abstract

Inventia se refera la medicina, in special la metode de tratament al mastopatiei difuze.Metoda, conform inventiei, consta in aceea ca initial pe parcursul a 5…6 saptamani se prescrie o dieta macrobiotica cu limitarea grasimilor si a proteinelor animale, totodata pe parcursul primelor 7…10 zile se administreaza un sorbent de 3 ori pe zi in cantitate eficienta cu 1 ora inainte de masa per os, dupa aceasta pe fondul dietei se administreaza un probiotic de 2-3 ori pe zi in timpul mesei in cantitateeficienta pe parcursul a 3…4 saptamani. Dupa finisarea dietei, in ziua a 9-a…a 13-a a ciclului menstrual, se efectueaza testarea prin electroacupunctura cu biorezonanta cu aplicarea unor electrozi cuplaci pe palmele, talpile pacientei si aplicarea unor electrozi magnetici pe glandele mamare, se actioneaza asupra pacientei cu unde electromagneticede 1…1000 Hz si densitatea fluxului de putere de 1,0…1,2 mW/cm2, se determina frecventa de biorezonanta a undelor, care duce la aparitia efectelor biologice. Apoi, timp de 17 min, se actioneaza cu unde de frecventa determinata asupra regiunii glandelor mamare cu alternarea perioadelor de excitare de 3 s si de relaxare de 1 s, dupa care se face inregistrarea campului electromagnetic al pacientei prin intermediul unor inductori magnetici timp de 3min pe un purtator inert, care se administreaza in cantitate eficienta pe parcursul a 2…3 saptamanide 1-3 ori pe zi sublingual. Seria de tratament cu unde electromagnetice include 2…3 sedinte la un interval de 3 saptamani.The invention relates to medicine, in particular to methods of treatment of diffuse mastopathy. The method, according to the invention, is that initially during 5 ... 6 weeks a macrobiotic diet is prescribed with limitation of animal fats and proteins, also during the first 7… 10 days a sorbent is administered 3 times a day in an efficient quantity with 1 hour before the meal per bone, after that on the background of the diet a probiotic is administered 2-3 times a day during the meal in the effective quantity during 3 … 4 weeks. After the completion of the diet, on the 9th… 13th of the menstrual cycle, the electroacupuncture with biorezoning is performed with the application of electrodes coupling on the palms, the patient's soles and the application of magnetic electrodes on the mammary glands, acting on the patient where electromagnetic from 1 ... 1000 Hz and the power flux density of 1.0 ... 1.2 mW / cm2, the frequency of wave bioresonance is determined, which leads to the occurrence of biological effects. Then, for 17 min, the wave frequency is determined on the mammary gland region, alternating the 3 s excitation and 1 s relaxation periods, after which the patient's electromagnetic field is recorded by magnetic inductors for 3 min. on an inert carrier, which is administered in an efficient quantity during 2 ... 3 weeks 1-3 times a day sublingually. The electromagnetic wave treatment series includes 2 ... 3 sessions at a 3 week interval.

MDA20070167A 2007-06-08 2007-06-08 Method of diffuse mastopathy treatment MD3678G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20070167A MD3678G2 (en) 2007-06-08 2007-06-08 Method of diffuse mastopathy treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20070167A MD3678G2 (en) 2007-06-08 2007-06-08 Method of diffuse mastopathy treatment

Publications (2)

Publication Number Publication Date
MD3678F1 true MD3678F1 (en) 2008-08-31
MD3678G2 MD3678G2 (en) 2009-03-31

Family

ID=39740099

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20070167A MD3678G2 (en) 2007-06-08 2007-06-08 Method of diffuse mastopathy treatment

Country Status (1)

Country Link
MD (1) MD3678G2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD65Z (en) * 2009-04-23 2010-03-31 Виталие МАКИДОН Noninvasive method for treating mammary fibroadenoma

Also Published As

Publication number Publication date
MD3678G2 (en) 2009-03-31

Similar Documents

Publication Publication Date Title
US4587956A (en) Reversible magnetic therapeutic device and method of use
Man et al. The influence of permanent magnetic field therapy on wound healing in suction lipectomy patients: a double-blind study
DE60312309D1 (en) USE OF BOTULINUM TOXIN TO TREAT HEART AND CIRCULAR DISEASES
IL214373A0 (en) Use of adipose tissue-derived cells in the preparation of a composition for the treatment of cardiovascular diseases
DE69737910D1 (en) DEVICE FOR TRANSCRANIAL STIMULATION OF THE BRAIN
DE69228000D1 (en) TREATMENT OF ACNE OR FOLLICULITIS BARBAE
DE60029591D1 (en) CONJUGATED LINOLIC ACID FOR THE TREATMENT OF CYCLOOXYGENASE-2 MEDIATED INFLAMMATION AND PAIN
CN114616026A (en) Electrical stimulation of tissue
MD3678F1 (en) Method of diffuse mastopathy treatment
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
GB0308323D0 (en) Electromagnetic stimulation in patients with osteoporosis
DE60334094D1 (en) USE OF PULLEY UTILINES FOR THE TREATMENT OF DISEASES CAUSED BY HELICOBACTER PYLORI
US20210251679A1 (en) Method and apparatus generator, concentrator and router of electromagnetic fields for cellular regeneration
WO2021052356A9 (en) Bone stimulator and bone stimulation system for bone fracture healing
PL377563A1 (en) Use of docosahexanoic acid as active substance for the treatment of lipodystrophy
CN101437572B (en) In vivo stimulation of cellular material
MD3646F1 (en) Method of treating chronic inflammatory diseases of female genital organs
Markoll et al. Pulsed signal therapy®: an overview
CN104874114A (en) System making use of low-intensity ultrasound to promote radiotherapy
EP4306096A1 (en) Intraoral apparatus and methods
CN203108005U (en) Novel gynecological dysmenorrhea magnetic-therapy protective pad
RU95109262A (en) Method of increasing efficiency of mudtherapy
MD3505F1 (en) Method of treating the endometrium hyperplasia
JP3030552U (en) Medical equipment
RU2002113429A (en) METHOD FOR TREATING PSORIASIS

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees